Cargando…
Concerns Regarding Therapeutic Implications of Very Low‐Level Dystrophin
Autores principales: | Hoffman, Eric P., Clemens, Paula R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251539/ https://www.ncbi.nlm.nih.gov/pubmed/33948977 http://dx.doi.org/10.1002/ana.26097 |
Ejemplares similares
-
Reply to F. Muntoni et al.: “In response to P.R. Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy
por: Clemens, Paula R., et al.
Publicado: (2023) -
Acute, severe and anaphylactoid reactions are very rare with low-molecular-weight iron dextran, CosmoFer®
por: Vaage-Nilsen, Odd
Publicado: (2008) -
Reply to Veerman et al. Comment on “Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410”
por: Rosenzweig, Barak, et al.
Publicado: (2022) -
Response letter regarding the letter to the editors by Brown et al.
por: Taylor, Sylvia, et al.
Publicado: (2016) -
Author’s Reply to “Concerns regarding Validity of the Use of Bean Extract-Based Gargle for COVID-19 Diagnosis”
por: Kwon, Joseph, et al.
Publicado: (2022)